1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-1125
  5. NDC Package Code: 0093-1125-89 Abiraterone Acetate

NDC Package 0093-1125-89 Abiraterone Acetate

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-1125-89
Package Description:
120 TABLET, FILM COATED in 1 BOTTLE
Product Code:
0093-1125
Proprietary Name:
Abiraterone Acetate
Usage Information:
This medication is used to treat prostate cancer. Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children.
11-Digit NDC Billing Format:
00093112589
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
120 EA
Labeler Name:
Teva Pharmaceuticals Usa, Inc.
Sample Package:
No
FDA Application Number:
ANDA208432
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
11-21-2018
End Marketing Date:
03-31-2021
Listing Expiration Date:
03-31-2021
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0093-1125-89?

The NDC Packaged Code 0093-1125-89 is assigned to a package of 120 tablet, film coated in 1 bottle of Abiraterone Acetate, labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is and is administered via form.

Is NDC 0093-1125 included in the NDC Directory?

No, Abiraterone Acetate with product code 0093-1125 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on November 21, 2018 and its listing in the NDC Directory is set to expire on March 31, 2021 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0093-1125-89?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 120.

What is the 11-digit format for NDC 0093-1125-89?

The 11-digit format is 00093112589. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20093-1125-895-4-200093-1125-89